Key result
Catheter-based radiofrequency ablation achieved technical success in 95.1% of PSVT and 92.2% of VA cases, with 94.5% of patients reporting complete symptom resolution at six months.
Why the study?
Radiofrequency ablation is a standard treatment for PSVT and VA, but data on its efficacy and safety in provincial-level hospitals are limited.
Observational (n=112)
No
Answers are grounded in this paper and cite their sources.
Radiofrequency ablation is an effective and safe treatment for paroxysmal supraventricular tachycardia and ventricular arrhythmias that can be successfully implemented in provincial-level hospitals.
Background Paroxysmal supraventricular tachycardia (PSVT) and ventricular arrhythmias (VA) are common cardiac rhythm disorders that can significantly impact quality of life and, in some cases, pose a risk of sudden cardiac death. Radiofrequency ablation (RFA) has emerged as a standard treatment modality, especially for patients who are unresponsive to or intolerant of pharmacological therapy. Objective To evaluate the efficacy and safety of catheter-based RFA in the treatment of PSVT and VA at Hoan My Cuu Long Hospital. Methods A prospective descriptive study was conducted on 112 patients (61 with PSVT and 51 with VA) who underwent electrophysiological study and RFA between April 2022 and June 2025. Patients were followed up for six months post-procedure. Outcome measures included technical success rate, symptom improvement, recurrence, and complication rates. Results The technical success rate was 95.1% for PSVT and 92.2% for VA. At six months, 94.5% of patients reported complete resolution of clinical symptoms such as palpitations, chest pain, and dizziness. The recurrence rates were 4.9% for PSVT and 7.8% for VA. The overall complication rate was 1.8%, with all complications being minor and managed conservatively. No procedure-related mortality was observed. Conclusion Radiofrequency ablation is an effective and safe treatment modality for both PSVT and VA. The procedure can be successfully implemented at provincial-level hospitals, contributing to the advancement of arrhythmia management in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) conducted an observational in Paroxysmal supraventricular tachycardia (PSVT) and ventricular arrhythmias (VA) (n=112). Catheter-based radiofrequency ablation was evaluated on Complete resolution of clinical symptoms at six months. Catheter-based radiofrequency ablation achieved technical success in 95.1% of PSVT and 92.2% of VA cases, with 94.5% of patients reporting complete symptom resolution at six months.
Synapse has enriched 10 related papers. Consider them for comparative context: